Retour

Explorez tous les épisodes du podcast MedEdTalks - Cardiology

Plongez dans la liste complète des épisodes de MedEdTalks - Cardiology. Chaque épisode est catalogué accompagné de descriptions détaillées, ce qui facilite la recherche et l'exploration de sujets spécifiques. Suivez tous les épisodes de votre podcast préféré et ne manquez aucun contenu pertinent.

Rows per page:

1–39 of 39

TitreDateDurée
Lipid Legends: Drs. James Underberg and Daniel Soffer Address Key Clinical Challenges in Hypertriglyceridemia (HTG)31 déc. 202500:32:13

In this episode, experts in the field summarize key clinical considerations in the assessment and treatment of patients with hypertriglyceridemia.

 

To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://www.healio.com/cme/mededtalks/cardiology/20251231/5lipid-legends

Lipid Legends: Drs. James Underberg and Anne Carol Goldberg Examine the Presentation and Management of Homozygous Familial Hypercholesterolemia31 déc. 202500:28:48

In this episode, experts in the field identify the presentation and appropriate management strategies for patients with homozygous familial hypercholesterolemia (HoFH). 

 

To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://www.healio.com/cme/mededtalks/cardiology/20251231/6lipid-legends

Lipid Legends: Drs. James Underberg and Zahid Ahmad Distinguish Lipodystrophy Syndromes and Their Treatment Approaches22 déc. 202500:27:58

In this episode, experts in the field distinguish between different types of lipodystrophy syndromes and their treatment approaches.

 

To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://www.healio.com/cme/mededtalks/cardiology/20251222/3lipid-legends

Lipid Legends: Drs. James Underberg and Don Wilson Review Diagnosis and Individualized Treatment of Pediatric Lipid Disorders22 déc. 202500:32:49

In this episode, experts in the field assess the evaluation and treatment of pediatric patients with lipid disorders, including familial hypercholesterolemia (FH) and lipodystrophy.

 

To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://www.healio.com/cme/mededtalks/cardiology/20251222/4lipid-legends

Lipid Legends: Drs. James Underberg and Pam Taub Discuss Reducing Cardiovascular Risk Through LDL-C Management15 déc. 202500:27:34

In this podcast, experts in the field review current recommendations for cardiovascular risk assessment and the importance of early and sustained LDL-C lowering in high-risk patients.

 

To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://www.healio.com/cme/mededtalks/cardiology/20251215/1lipid-legends

Lipid Legends: Drs. James Underberg and Howard Weintraub Describe the Role of Lp(a) and Potential Impact of Emerging Therapies15 déc. 202500:31:42

The Lipid Legends podcast series highlights accomplished lipid specialists to highlight clinical challenges and provide actionable insights into disorders. In this episode, experts in the field describe the role of Lp(a) in atherogenesis and the potential impact of emerging therapies on clinical outcomes.

 

To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://www.healio.com/cme/mededtalks/cardiology/20251215/2lipid-legends

Lipid Legends With Your Host Dr. Ronald Codario, Featuring Dr. Alan Brown: Lp(a) – What You Need to Know14 mars 202500:31:43

In this podcast, expert clinicians will discuss the role of lipoprotein(a) [Lp(a)] in atherogenesis and emerging therapies that reduce Lp(a).

To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box:
https://healio.com/cme/mededtalks/cardiology/20250303/5-lipid-legends-with-your-host-dr-ronald-codario

Lipid Legends With Your Host Dr. Ronald Codario, Featuring Dr. James Underberg: Familial Hypercholesterolemia – Risk Assessment and Treatment28 févr. 202500:33:25

In this podcast, expert clinicians will assess the latest understanding regarding homozygous and heterozygous familial hypercholesterolemia (FH), risk assessment, and options for management.

To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box:
https://healio.com/cme/mededtalks/cardiology/20250211/3-lipid-legends-with-your-host-dr-ronald-codario-featuring-dr-james-underberg

Read More  
Lipid Legends With Your Host Dr. Ronald Codario, Featuring Dr. Peter Toth: PCSK9 Inhibition15 janv. 202500:36:28

In this podcast, expert clinicians will review the role of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in reducing low-density lipoprotein cholesterol (LDL-C) and reducing cardiovascular risk.

To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box:
https://healio.com/cme/mededtalks/cardiology/20250102/4-lipid-legends-with-your-host-dr-ronald-codario-featuring-dr-peter-toth-pcsk9-inhibition

Lipid Legends With Your Host Dr. Ronald Codario, Featuring Dr. Thomas Dayspring: Perils of Hypertriglyceridemia16 déc. 202400:34:29

In this podcast, expert clinicians will discuss clinical challenges related to hypertriglyceridemia and its therapies.

To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box:
https://healio.com/cme/mededtalks/cardiology/20241125/6-lipid-legends-with-your-host-dr-ronald-codario-featuring-dr-thomas-dayspring-perils

Lipid Legends With Your Host Dr. Ronald Codario, Featuring Dr. Christie Ballantyne: CETP Inhibition15 nov. 202400:27:27

In this podcast, expert clinicians will discuss the latest evidence regarding the role of cholesteryl ester transfer protein (CETP) inhibitors in the management of patients with dyslipidemia.

To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box:
https://healio.com/cme/mededtalks/cardiology/20241104/2-lipid-legends-with-your-host-dr-ronald-codario

Lipid Legends With Your Host Dr. Ronald Codario, Featuring Dr. Michael Davidson: Assessing Cardiovascular Risk31 oct. 202400:35:37

In this podcast, expert clinicians will discuss the latest recommendations to assess cardiovascular risk, residual risk, and low-density lipoprotein cholesterol (LDL-C) goals for therapy. 

To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box:
https://healio.com/cme/mededtalks/cardiology/20241028/1-lipid-legends-with-your-host-dr-ronald-codario

sGC Modulators in HFrEF: MOA, Clinical Evidence, With Drs. IIeana Pina and Javed Butler23 août 202300:15:13

In this podcast, expert clinicians will discuss the mechanism of action of and clinical evidence for the use of soluble guanylate cyclase (sGC) modulators in heart failure with reduced ejection fraction (HFrEF).

Updated Guidelines Recommendations for the Management of HFrEF and Worsening HF, With Drs. Ileana Pina and Shelley Zieroth23 août 202300:13:44

In this podcast, expert clinicians will discuss the updated guideline recommendations for the management of heart failure with reduced ejection fraction (HFrEF) and worsening HF.

Burden of HFrEF and Worsening HF, With Drs. Ileana Piña and Javed Butler23 août 202300:17:40

In this podcast, expert clinicians will discuss the burden of HFrEF and worsening HF.

Case Discussion: ASCVD Risk Reduction With Drs. Peter Toth and Amit Khera02 juin 202200:16:43

In this podcast, expert clinicians will discuss evidence-based management of CV risk reduction.

Clinical Evidence for Omega-3 Polyunsaturated Fatty Acids for Managing ASCVD Risk With Drs. Peter Toth and Pam Taub02 juin 202200:15:46

Clinical Evidence for Omega-3 PUFAs for Managing CV Risk with Drs. Peter Toth and Pam Taub.

The Impact of Omega-3 PUFAs on ASCVD Risk Reduction With Drs. Peter Toth and Amit Khera02 juin 202200:18:54

The Impact of Omega-3 PUFAs on CV Risk Reduction with Drs. Peter Toth and Amit Khera.

The Role of Inflammation in Atherosclerosis With Drs. Peter Toth and Pam Taub02 juin 202200:13:55

In this podcast, expert clinicians will discuss the role of inflammation in atherosclerosis.

Challenges in Embolic Stroke: Deciding Between Combination Medical and PFO Closure or Medical Management Alone With Drs. Howard Herrmann and John Carroll27 avr. 202200:18:33

In this podcast, expert clinicians will discuss management selection for embolic stroke with a PFO.

Challenges in Embolic Stroke: Embolic Stroke Treatment With Drs. Howard Herrmann and John Carroll27 avr. 202200:16:37

In this podcast, expert clinicians will discuss treatment options for embolic stroke due to a PFO.

Challenges in Embolic Stroke: Getting With the Guidelines – PFO Closure and the Use of Medical Therapy With Drs. Howard Herrmann and Scott Kasner27 avr. 202200:14:18

In this podcast, expert clinicians will discuss the current guidelines for the management of embolic stroke with a PFO.

Challenges in Embolic Stroke: Confronting Challenges in Diagnosis With Drs. Howard Herrmann and Scott Kasner27 avr. 202200:17:20

In this podcast, expert clinicians will discuss challenges in the diagnosis of embolic stroke with a PFO.

PFO Closure: Procedural Pearls and Important Considerations with Drs. Herrmann, Carroll, and Kasner29 avr. 202100:14:36

In this podcast, expert clinicians will share procedural pearls for PFO closure and important considerations to optimize patient outcomes. 

Managing Patients With Cryptogenic Stroke: Clinical Perspectives, with Drs. Herrmann, Carroll, and Kasner29 avr. 202100:13:52

In this podcast, expert clinicians will discuss management of patients with cryptogenic stroke as well as strategies for applying new guideline recommendations into practice.

The Relationship Between PFO and Cryptogenic Stroke: Reviewing the Data, with Drs. Herrmann, Carroll, and Kasner29 avr. 202100:15:28

In this podcast, expert clinicians will discuss the association between patent foramen ovale and stroke and review the current clinical data to support PFO closure.

Diagnosis and Classification of Cryptogenic Stroke and PFO-Associated Stroke, with Drs. Herrmann, Carroll, and Kasner29 avr. 202100:16:28

In this podcast, expert clinicians will discuss strategies for classification and workup of cryptogenic stroke and PFO-associated stroke.

Recent Cardiovascular Outcomes Trials: Reducing Triglycerides for Further Risk Reduction with Drs. Pamela Morris and Deepak Bhatt24 mars 202100:16:25

In this podcast, expert clinicians will discuss latest clinical evidence from cardiovascular outcomes trials and how reducing triglycerides for further reduces risk.

Deep Dive Into Clinical Evidence: Reducing CVD risk through LDL-C reduction with Drs. Pamela Morris and Ann Marie Navar24 mars 202100:17:10

In this podcast, expert clinicians will discuss evidence regarding mitigating cardiovascular risk by LDL-C reduction.

Patient Identification for Residual Risk Management: Who's At Risk? with Drs. Pamela Morris and Martha Gulati24 mars 202100:11:58

In this podcast, expert clinicians will discuss secondary prevention and how to identify patients who may benefit from additional treatment to reduce CV risk.

Strategies for Atherosclerotic Cardiovascular Disease (ASCVD) Risk Assessment: What's the Risk? with Drs. Pamela Morris and Martha Gulati24 mars 202100:15:26

In this podcast, expert clinicians discuss primary prevention as well as strategies for ASCVD risk assessment.

sGC Modulators: Role in Current Treatment Paradigms for Heart Failure With Drs. Paul Armstrong and Javed Butler16 déc. 202000:14:46

In this podcast, expert clinicians will discuss the potential use of sGC modulators in the management of patients with heart failure with reduced ejection fraction (HFrEF).

The Clinical Evidence: Efficacy and Safety of sGC Modulators in Heart Failure With Reduced Ejection Fraction With Drs. Paul Armstrong and Javed Butler16 déc. 202000:14:54

In this podcast, expert clinicians will discuss the safety and efficacy of sGC modulators that was seen in various clinical trials.

sGC Modulators: Unique Mechanism of Action and Rationale for Use in Heart Failure With Drs. Paul Armstrong and Carolyn Lam16 déc. 202000:11:18

In this podcast, expert clinicians will discuss the mechanism of action of sGC modulators and the rationale for its use in patients with heart failure.

Heart Failure Management: Guideline-directed Therapy and Unmet Needs With Drs. Paul Armstrong and Carolyn Lam16 déc. 202000:14:15

In this podcast, expert clinicians will discuss the burden of heart failure in the United States and the potential of new therapies for treating heart failure.

Cardiovascular Risk Reduction in Patients with Diabetes: Coordinating Efforts Between Cardiologists and Endocrinologists; Blood Pressure Control and Optimizing Care Coordination and Medication Management08 janv. 202000:10:52

In this podcast, Deepak L. Bhatt, MD, and Peter P. Toth, MD, PhD, discuss blood pressure control as well as optimizing care coordination and medication management in the patient with diabetes.

Transcript: https://tinyurl.com/yj8zwh69

To earn CME credit, go here: https://cme.healio.com/mededtalks/cardiology/2019/12_december/mededtalks-in-cardiology-blood-pressure-control-and-optimizing-care-coordination-and-medication

Cardiovascular Risk Reduction in Patients with Diabetes: Coordinating Efforts Between Cardiologists and Endocrinologists; Reducing CV Risk in Patients With Diabetes – A Discussion on the Latest Data08 janv. 202000:13:00

In this podcast, Deepak L. Bhatt, MD, and Peter P. Toth, MD, PhD, discuss the latest data on reducing CV risk in patients with diabetes.

Transcript: https://tinyurl.com/yeendrms

To earn CME Credit, go here: https://cme.healio.com/mededtalks/cardiology/2019/12_december/mededtalks-in-cardiology-reducing-cv-risk-in-patients-with-diabetes-a-discussion-on-the-latest-data

Cardiovascular Risk Reduction in Patients with Diabetes: Coordinating Efforts Between Cardiologists and Endocrinologists; The Interplay Between T2DM and CV Risk – Implications for Patients08 janv. 202000:12:31

In this podcast, Deepak L. Bhatt, MD, and Peter P. Toth, MD, PhD, discuss the interplay between T2DM and CV risk.  

Transcript: https://tinyurl.com/yh9kt3al

To earn CME credits, go here: https://cme.healio.com/mededtalks/cardiology/2019/12_december/mededtalks-in-cardiology-the-interplay-between-t2dm-and-cv-risk-implications-for-patients

MedEd Talks in Cardiology - Cardiovascular Risk Reduction in Patients with Diabetes: Coordinating Efforts Between Cardiologists and Endocrinologists08 janv. 202000:01:04
© My Podcast Data · Projet indépendant · Données issues d'Apple & Spotify